NOVAVAX INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Novavax Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Novavax Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 162M shares, a 35% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 162M +41.9M +35% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 161M +66.1M +69.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 142M +54.6M +62.6% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 141M +53.7M +61.9% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 120M +40.4M +51.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 95.2M +16.4M +20.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 87.1M +8.42M +10.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 86.8M +10.4M +13.6% Dec 31, 2022 10-K 2024-02-28
Q3 2022 79.2M +3.23M +4.25% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 78.8M +4.1M +5.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 78.7M +4.25M +5.71% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 76.4M +5.08M +7.12% Dec 31, 2021 10-K 2023-02-28
Q3 2021 76M +12.7M +20% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 74.7M +13.4M +21.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 74.5M +20.6M +38.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 71.4M +39M +120% Dec 31, 2020 10-K 2022-03-01
Q3 2020 63.3M +37.7M +148% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 61.3M +37.8M +161% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 53.9M -416M -88.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 32.4M +13.2M +68.3% Dec 31, 2019 10-K 2021-03-01
Q3 2019 25.6M -358M -93.3% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 23.5M -359M -93.9% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 470M +123M +35.3% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 19.2M -304M -94.1% Dec 31, 2018 10-K 2020-03-11
Q3 2018 383M +72.5M +23.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 382M +91.8M +31.6% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 347M +64.1M +22.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 324M +52M +19.1% Dec 31, 2017 10-K 2019-03-18
Q3 2017 311M +38.9M +14.3% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 290M +19M +7.02% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 283M +11.8M +4.37% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 272M +1.27M +0.47% Dec 31, 2016 10-K 2018-03-14
Q3 2016 272M +1.42M +0.53% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 271M +2.24M +0.83% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 271M +2.84M +1.06% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 270M +31.1M +13% Dec 31, 2015 10-K 2017-02-27
Q3 2015 270M +31.4M +13.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 269M +30.5M +12.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 268M +58.7M +28% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 239M +30.2M +14.4% Dec 31, 2014 10-K 2016-02-29
Q3 2014 239M +29.9M +14.3% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 239M +85.4M +55.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 210M +58M +38.2% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 209M +60.7M +40.9% Dec 31, 2013 10-K 2015-02-27
Q3 2013 209M +73M +53.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 153M +20.6M +15.5% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 152M +29.1M +23.8% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 148M +30.9M +26.3% Dec 31, 2012 10-K 2014-03-12
Q3 2012 136M +20.6M +17.9% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 133M +17.5M +15.2% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 123M Mar 31, 2012 10-Q 2012-05-09
Q4 2011 117M +5.99M +5.37% Dec 31, 2011 10-K 2013-03-12
Q3 2011 115M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 115M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 111M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.